Brookwood Investment Group LLC acquired a new stake in Centene Corporation (NYSE:CNC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,923 shares of the company's stock, valued at approximately $1,396,000.
Several other large investors also recently bought and sold shares of the stock. Jackson Thornton Wealth Management LLC boosted its stake in Centene by 94.6% in the fourth quarter. Jackson Thornton Wealth Management LLC now owns 28,204 shares of the company's stock valued at $1,161,000 after acquiring an additional 13,707 shares in the last quarter. V Square Quantitative Management LLC acquired a new stake in shares of Centene in the fourth quarter valued at approximately $359,000. Personal CFO Solutions LLC acquired a new stake in shares of Centene in the fourth quarter valued at approximately $224,000. Prime Capital Investment Advisors LLC boosted its holdings in shares of Centene by 5.7% in the fourth quarter. Prime Capital Investment Advisors LLC now owns 5,975 shares of the company's stock valued at $246,000 after acquiring an additional 324 shares during the period. Finally, Oak Thistle LLC acquired a new stake in shares of Centene in the fourth quarter valued at approximately $740,000. Institutional investors and hedge funds own 93.63% of the company's stock.
Centene Price Performance
Shares of NYSE CNC opened at $37.54 on Friday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10. The stock has a fifty day moving average price of $38.66 and a 200 day moving average price of $38.84. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $64.15. The company has a market cap of $18.46 billion, a PE ratio of -2.76, a P/E/G ratio of 0.83 and a beta of 0.59.
Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping the consensus estimate of ($1.22) by $0.03. The firm had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The company's revenue for the quarter was up 21.9% on a year-over-year basis. During the same period last year, the company earned $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Sell-side analysts forecast that Centene Corporation will post 6.86 EPS for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Jefferies Financial Group decreased their price objective on Centene from $43.00 to $37.00 and set a "hold" rating for the company in a report on Friday, February 13th. Mizuho set a $41.00 price objective on Centene and gave the company a "neutral" rating in a report on Tuesday, March 10th. Truist Financial increased their target price on shares of Centene from $47.00 to $49.00 and gave the stock a "buy" rating in a research note on Wednesday, February 25th. Robert W. Baird increased their target price on shares of Centene from $28.00 to $36.00 and gave the stock a "neutral" rating in a research note on Thursday, December 11th. Finally, Morgan Stanley increased their target price on shares of Centene from $38.00 to $45.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 4th. Three investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $41.81.
View Our Latest Stock Analysis on CNC
About Centene
(
Free Report)
Centene Corporation NYSE: CNC is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.